Propanc Biopharma PPCB
Propanc Biopharma: securities offering (amended)
- Form
- S-1/A
- Filed
- Importance
- Routine
- Accession
- 0001641172-25-001355
- Document
- S-1/A
- Exhibit 1.1
- Underwriting or sales agreement
- Exhibit 10.42
- Material contract
- Exhibit 10.45
- Material contract
- Exhibit 10.46
- Material contract
- Exhibit 10.47
- Material contract
- Exhibit 10.48
- Material contract
- Exhibit 10.49
- Material contract
- Exhibit 10.50
- Material contract
- Exhibit 10.51
- Material contract
- Exhibit 10.52
- Material contract
- Exhibit 10.53
- Material contract
- Exhibit 10.54
- Material contract
- Exhibit 10.55
- Material contract
- Exhibit 10.56
- Material contract
- Exhibit 10.57
- Material contract
- Exhibit 10.58
- Material contract
- Exhibit 10.59
- Material contract
- Exhibit 99.1
- Press release
Not explained yet; the original is on EDGAR.
Securities offering (amended)
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Cannapharmarx CPMD public float $3M, Jun 30, 2025
- MetaVia MTVA public float $3M, Jun 30, 2025
- Oragenics OGEN public float $3M, Jun 30, 2025
- Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
- PTC Therapeutics PTCT public float $3M, Jun 30, 2025